Head of U.S. Payer Value Strategy, and Innovation
Jeremy Schafer is the Head of U.S. Payer Value Strategy, and Innovation at UCB. In this role, Jeremy leads a team developing value-based partnerships and strategies to enhance market access across the UCB portfolio including immunology, neurology, and rare disease, including directing strategy for specialty and strategic markets. He also collaborates across the business to create compelling Real-World Evidence (RWE) data and models for market access customers.
Jeremy began his career at one of the top 5 largest Pharmacy Benefit Managers, holding a variety of leadership roles in formulary, utilization management, and specialty pharmacy. He also served as a Corporate Account Manager for a pharmaceutical manufacturer focused on rare disease, where he engaged payers to educate decision-makers on portfolio products and enhance access for providers and patients. More recently, he served in an executive leadership role at a market access agency, where he and his team assisted pharmaceutical manufacturer clients develop payer value propositions and other marketing tactics to improve patient access to medicines.
Jeremy is a prolific writer and has authored more than 50 published articles in healthcare journals and the press with the majority focused on market access topics. He was awarded a “40 under 40 in Cancer” award for his work in improving access to cancer therapies for patients.
Jeremy is a member of the Academy of Managed Care Pharmacy and a board member for the National Association of Specialty Pharmacy (NASP).
Jeremy has a Doctor of Pharmacy degree from the University of Minnesota and an MBA from Bethel University in St Paul, Minnesota. Jeremy resides in Minnesota with his wife Rhonda, son Billy, daughter Kylie, and mini bernedoodle Hunter.